Discovery of novel pyrazole derivatives as a potent anti-inflammatory agent in RAW264.7 cells via inhibition of NF-kappa B for possible benefit against SARS-CoV-2 von Masih, Anup, Agnihotri, Amol K., Srivastava, Jitendra K., Pandey, Nidhi, Bhat, Hans R., Singh, Udaya P.

Volltext

Design, synthesis, anticancer, antibacterial, and antifungal evaluation of 4‐aminoquinoline‐1,3,5‐triazine derivatives von Bhat, Hans Raj, Masih, Anup, Shakya, Anshul, Ghosh, Surajit Kumar, Singh, Udaya Pratap

Volltext

Design and development of 1,3,5-triazine-thiadiazole hybrids as potent adenosine A(2)A receptor (A(2)AR) antagonist for benefit in Parkinson's disease von Masih, Anup, Singh, Saumya, Agnihotri, Amol Kumar, Giri, Sabeena, Shrivastava, Jitendra Kumar, Pandey, Nidhi, Bhat, Hans Raj, Singh, Udaya Pratap

Volltext

1,3,5‐Triazine: A versatile pharmacophore with diverse biological activities von Singh, Saumya, Mandal, Milan K., Masih, Anup, Saha, Ashmita, Ghosh, Surajit K., Bhat, Hans R., Singh, Udaya P.

Volltext

Discovery of novel pyrazole derivatives as a potent anti‐inflammatory agent in RAW264.7 cells via inhibition of NF‐ĸB for possible benefit against SARS‐CoV‐2 von Masih, Anup, Agnihotri, Amol K., Srivastava, Jitendra K., Pandey, Nidhi, Bhat, Hans R., Singh, Udaya P.

Volltext

Discovery of novel 1,3,5‐triazine as adenosine A2A receptor antagonist for benefit in Parkinson's disease von Masih, Anup, Agnihotri, Amol K., Srivastava, Jitendra K., Pandey, Nidhi, Bhat, Hans R., Singh, Udaya P.

Volltext

Design and development of 1,3,5-triazine-thiadiazole hybrids as potent adenosine A 2 A receptor (A 2 AR) antagonist for benefit in Parkinson's disease von Masih, Anup, Singh, Saumya, Agnihotri, Amol Kumar, Giri, Sabeena, Shrivastava, Jitendra Kumar, Pandey, Nidhi, Bhat, Hans Raj, Singh, Udaya Pratap

Volltext